Peripheral Serotonergic Activation in Severe Aortic Stenosis: A Biochemical Perspective

Area of Science:

• Cardiovascular Medicine
• Biochemistry
• Pathophysiology

Background:

• Calcific aortic stenosis (AS) is a complex cardiovascular condition.
• The serotonergic system's involvement in AS pathogenesis is an emerging area of research.

Purpose of the Study:

• To investigate serum concentrations of serotonin (5-HT) and its metabolite 5-Hydroxyindoleacetic acid (5-HIAA) in patients with severe AS.
• To assess the potential role of the peripheral serotonergic system in AS pathophysiology.

Main Methods:

• Case-control study involving 76 patients with severe AS and controls.
• Transthoracic echocardiography, computed tomography (CT), and peripheral blood sampling were performed.
• Serum 5-HT and 5-HIAA levels were quantified using enzyme-linked immunosorbent assay (ELISA).

Main Results:

• Patients with severe AS showed significantly higher serum levels of 5-HT and 5-HIAA compared to controls.
• 5-HT levels were 1066.5 ng/mL (IQR = 961.9-1112) vs. 977.4 ng/mL (IQR = 394.3-1097.9), p=0.034.
• 5-HIAA levels were 57 ± 12.7 ng/mL vs. 47.5 ± 15.3 ng/mL, p=0.004.

Conclusions:

• Significant elevation of 5-HT and 5-HIAA in severe AS patients supports the involvement of the peripheral serotonergic system.
• Further research is warranted to elucidate the precise mechanisms linking serotonin pathways to AS development and progression.